GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mendus AB (CHIX:IMMUs) » Definitions » Float Percentage Of Total Shares Outstanding

Mendus AB (CHIX:IMMUS) Float Percentage Of Total Shares Outstanding : 0.00% (As of May. 29, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Mendus AB Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Mendus AB's float shares is 0.00 Mil. Mendus AB's total shares outstanding is 1,007.19 Mil. Mendus AB's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Mendus AB's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Mendus AB's Institutional Ownership is 1.43%.

Mendus AB Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Mendus AB's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/1,007.19
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mendus AB (CHIX:IMMUS) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mendus AB (CHIX:IMMUs) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
OSTO:SANION OSTO:GUARD OSTO:IRLAB A OSTO:NICA OSTO:KAN OSTO:CLBIO OSTO:ACOU OSTO:MVIR OSTO:KDEV OSTO:MAGLE OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
IMMU:Sweden 1YG:Germany
Address
Vastra Tradgardsgatan 15, Stockholm, SWE, 11153
Website
https://www.mendus.com
Mendus AB is a clinical-level biopharmaceutical company that focuses on the development of immunotherapies that address tumor recurrence and difficult-to-treat established tumors. Its operations consist of research and development for pharmaceuticals.

Mendus AB (CHIX:IMMUS) Headlines

No Headlines